Ketamine is an NMDA receptor antagonist with a potent anesthetic effect. It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic eff...
Ketamine is indicated as an anesthetic agent for recommended diagnostic and surgical procedures. If skeletal muscle relaxation is needed, it should be combined with a muscle relaxant. If the surgical procedure involves visceral pain, it should be supplemented with an agent that obtunds visceral pain. Ketamine can be used for induction of anesthesia prior oth...
Mount Sinai School of Medicine, New York, New York, United States
Clermont-Ferrand University Hospital, Clermont-Ferrand, France
Vilnius University Emergency Hospital, Vilnius, Lithuania
The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest, Bordeaux, France
Nantes University Hospital, Nantes, France
Washington University School of Medicine, Psychiatry Dept., St. Louis, Missouri, United States
The Alfred Commercial Rd Prahran, Melbourne, Victoria, Australia
Queen's University, Kingston, Ontario, Canada
Centre Hospitalier Lyon Sud, Pierre bénite, France
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.